Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)
Ali Yılmaz, Johann Bauersachs, Frank M. Bengel, et al.
Clinical Research in Cardiology (2021) Vol. 110, Iss. 4, pp. 479-506
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
Alberto Aimo, Marco Merlo, Aldostefano Porcari, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2342-2351
Open Access | Times Cited: 120
Restrictive cardiomyopathy: definition and diagnosis
Claudio Rapezzi, Alberto Aimo, Andrea Barison, et al.
European Heart Journal (2022) Vol. 43, Iss. 45, pp. 4679-4693
Open Access | Times Cited: 110
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis
Claudio Rapezzi, Alberto Aimo, Matteo Serenelli, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 13, pp. 1288-1303
Open Access | Times Cited: 72
Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca – 2021
Marcus Vinı́cius Simões, Fábio Fernandes, Fabiana G. Marcondes‐Braga, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 117, Iss. 3, pp. 561-598
Open Access | Times Cited: 64
Clinical application of CMR in cardiomyopathies: evolving concepts and techniques
Marco Merlo, Giulia Gagno, Anna Baritussio, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 1, pp. 77-95
Open Access | Times Cited: 53
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Dulce Brito, Fabiano Castro Albrecht, Diego Pérez de Arenaza, et al.
Global Heart (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 40
Cardiac Amyloidosis
Michelle Bloom, Peter D. Gorevic
Annals of Internal Medicine (2023) Vol. 176, Iss. 3, pp. ITC33-ITC48
Closed Access | Times Cited: 36
Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)—An Important Risk Marker for Cardiac Disease
Claudia Meier, Michel Eisenblätter, Stephan Gielen
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 2, pp. 40-40
Open Access | Times Cited: 12
Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment
Julia Vogel, Alexander Carpinteiro, Peter Luedike, et al.
Current Heart Failure Reports (2024) Vol. 21, Iss. 4, pp. 305-321
Open Access | Times Cited: 7
Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)
С. Н. Терещенко, И. В. Жиров, О. М. Моисеева, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 4, pp. 584-595
Open Access | Times Cited: 24
Invasive and Non-Invasive Diagnostic Pathways in the Diagnosis of Cardiac Amyloidosis
Αlexandros Briasoulis, Dimitrios Bampatsias, Adamantia Papamichail, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 6, pp. 256-256
Open Access | Times Cited: 15
Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging
Bishwas Chamling, Michael Bietenbeck, Dennis Korthals, et al.
Clinical Research in Cardiology (2022) Vol. 112, Iss. 3, pp. 353-362
Open Access | Times Cited: 22
A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging
Florent L. Besson, Giorgio Treglia, Jan Bucerius, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2247-2259
Open Access | Times Cited: 4
Amyloidosis and Amyloidogenesis
Marco Pozzan, Carla Indennidate, Guerino Giuseppe Varrà, et al.
Heart Failure Clinics (2024) Vol. 20, Iss. 3, pp. 249-260
Closed Access | Times Cited: 4
CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis
Dennis Korthals, Grigorios Chatzantonis, Michael Bietenbeck, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies
Johann Bauersachs, Rudolf A. de Boer, JoAnn Lindenfeld, et al.
European Heart Journal (2021) Vol. 43, Iss. 5, pp. 367-376
Open Access | Times Cited: 24
Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
Katrine Bay, Finn Gustafsson, Michael Maiborg, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 3, pp. 1524-1541
Open Access | Times Cited: 18
Health‐related quality of life among transthyretin amyloid cardiomyopathy patients
Per Eldhagen, Jukka Lehtonen, Einar Gude, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 3, pp. 1871-1882
Open Access | Times Cited: 11
Diagnostic value of bone scintigraphy versus CMR in cardiac amyloidosis
J Obergassel, Michael Bietenbeck, Nuriye Akyol, et al.
Journal of Cardiovascular Magnetic Resonance (2025), pp. 101859-101859
Open Access
Portuguese recommendations for the management of transthyretin amyloid cardiomyopathy (Part 1 of 2): Screening, diagnosis and treatment. Developed by the Task Force on the management of transthyretin amyloid cardiomyopathy of the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology
Nuno Marques, Sílvia Aguiar Rosa, Filipa Cordeiro, et al.
Revista Portuguesa de Cardiologia (2025) Vol. 44, pp. 7-48
Open Access
Guideline-Directed Medical Therapy for Heart Failure in Transthyretin Amyloid Cardiomyopathy
Stéphanie K. Schwarting, Thomas Bieber, Daniel R. Davies, et al.
Circulation Heart Failure (2025)
Closed Access
Cardiac amyloidosis: Innovations in diagnosis and treatment
Vincenzo Castiglione, Sabrina Montuoro, Giulia Orlando, et al.
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_1, pp. i88-i97
Open Access
Depressive symptoms delayed but subsequently led to the diagnosis of transthyretin amyloidosis: a case report
Vladimir Knežević, Dragana Ratković, Željko Živanović, et al.
Journal of International Medical Research (2025) Vol. 53, Iss. 2
Open Access
Advances and challenges in echocardiographic diagnosis and management of cardiac amyloidosis
Tian Yun, Haibin Liu
The International Journal of Cardiovascular Imaging (2025)
Closed Access
DGK-Positionspapier zur Schnittbildgebung Teil II: Kardiale Magnetresonanztomographie zur periprozeduralen Planung und Durchführung von kardialen Interventionen
Torben Lange, Nadine Abanador-Kamper, Peter Bernhardt, et al.
Deleted Journal (2025)
Closed Access
Page 1 - Next Page

Scroll to top